A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the appropriate dose of fluticasone
propionate/formoterol fumarate that is closest to Advair Diskus (fluticasone
propionate/salmeterol xinafoate using pulmonary function, safety, and levels of study drug in
blood plasma in patients with chronic obstructive pulmonary disease.